Dose Titration and Glycemic Control With Insulin Glargine 100 U/Ml in Previously Uncontrolled Patients With Type 2 Diabetes: A 6-Month Prospective Observational Study in Primary Care in Lebanon.

International Journal of Advanced Research
doi 10.21474/ijar01/8404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Journal Of Advanced Research

Related search

Pdb86 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pdb79 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Croatia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Glycaemic Control, Hypoglycaemia, and Weight Change With Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Japanese Adults With Type 2 Diabetes: A 12-Month Comparison by Concomitant Sulphonylurea and/or Glinide Use

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Real-World Outcomes of Treatment With Insulin Glargine 300 u/mL Versus Standard-Of-Care in People With Uncontrolled Type 2 Diabetes Mellitus

Current Medical Research and Opinion
Medicine
2020English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Insulin/Carbohydrates Ratio During the First 6‐month Therapy With Insulin Degludec in a Paediatric Population With Type 1 Diabetes Previously Treated With Insulin Glargine. An Observational Longitudinal Study

Endocrinology, Diabetes & Metabolism
2020English

In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Association of Patient Profile With Glycemic Control and Hypoglycemia With Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Commencing Insulin Glargine 100 U/mL Therapy in People With Type 2 Diabetes: Determinants of Achievement of HbA1c Goal <7.0%

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy